European Markets for Soft Tissue Repair Devices 2011

Introduction:

Fueled by the increasing adoption of commercial products, the market for soft tissue repair devices in Europe will experience strong growth over the forecast period. Because these products cause less pain for the patient and are easier for physicians to use, they boost procedural efficiency. The market will also experience strong expansion due to the adoption of premium-priced devices—including biologic hernia meshes for ventral hernia repair, pelvic floor reconstruction kits for pelvic organ prolapse (POP), and proprietary meshes for inguinal hernia repair—that offer clinical and technical advantages over lower-cost devices. Through 2015, demographic trends will drive procedural growth in the ventral hernia, inguinal hernia, and pelvic floor reconstruction markets—all of which may entail the use of a commercial mesh. At the same time, limited reimbursement, a lack of clinical evidence for technologically advanced products, and competition from alternative treatments—such as nonsurgical methods of treating POP and minimally invasive cranial surgical techniques—will limit the overall market.

Questions Answered in This Report:

• Biologic meshes are growing in popularity in the US due to surgeon confidence and perceived superior performance in complicated ventral hernias. What impact will biologic meshes have on the European ventral hernia repair device market? How will the market for biologic meshes grow relative to the synthetic mesh segment?
• In the US, single-incision slings will show double-digit growth over the forecast period. Will single-incision slings show significant adoption in Europe?
• Historically, suture plication pelvic floor procedures have been the primary method for treating POP. What is the potential for commercial mesh procedures in the pelvic floor reconstruction market?
• Proprietary inguinal hernia meshes offer numerous patient benefits, including the ability to encourage tissue ingrowth and absorption. This type of mesh is, however, priced significantly higher than flatsheet meshes. Given the price disparity between proprietary and flatsheet meshes, will proprietary inguinal hernia repair meshes be adopted in Europe over the forecast period?

Scope:

Regions covered: France, Germany, Italy, UK

Procedure segmentation: Our analysis uses the following breakdown of procedures:

• Ventral hernia repairs
• Tension repairs
• Tension-free repairs (laparoscopic and open)
• Vaginal sling procedures
• Commercial (fixationless and traditional)
• Autologous
• Inguinal hernia repairs
• Tension repairs
• Tension-free repairs (laparoscopic and open)
• Pelvic floor reconstruction
• Suture plication
• Commercial mesh (xenografts [single units], synthetic [single units], and pelvic kits)
• Autologous
• Dural repairs
• By indication (cranial and spinal)
• By material (autogolous, commercial mesh, and non-mesh)

Market segmentation: Our analysis uses the following breakdown of the market:

• Ventral hernia repair devices
• Synthetic (nonadhesive and flatsheet)
• Biologic
• Vaginal slings
• Fixationless transobturator
• Standard transobturator
• Inguinal hernia repair devices
• Proprietary
• Flatsheet
• Pelvic floor reconstruction devices
• Synthetic (pelvic floor reconstruction kits and single units)
• Biologic (pelvic floor reconstruction kits and single units)
• Dural repair devices
• Xenograft mesh
• Synthetic mesh

Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period (2009–2015).

Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.